Genetic Technologies (GENE) announces the appointment of Mark Ziirsen as Chief Financial Officer, CFO, and Company Secretary. Mark is a globally experienced ASX and Nasdaq listed CFO and company secretary with more than 25 years’ experience operating across life sciences, technology and consumer segments that include senior finance leadership roles with major ASX listed companies including Cochlear (CHEOY).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GENE:
- Genetic Technologies to enter Canadian, New Zealand markets
- GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
- GTG’s GeneType identifies 79.5% of people tested at risk of serious disease
- Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
- Genetic Technologies expands operation capacity in North America